Chat with Nancy Carnevale
Thoracic Surgeon and Innovator
About Nancy Carnevale
In 2017, Nancy Carnevale led the first U.S. clinical trial integrating real-time intraoperative optical coherence tomography (OCT) with robotic-assisted esophagectomy, enabling millimeter-precise tumor margin assessment without freezing sections or delaying reconstruction. Her lab at Brigham and Women’s pioneered the 'lung-sparing segmentectomy map,' a dynamic 3D surgical planning tool now embedded in three FDA-cleared navigation platforms. Unlike peers who prioritize speed or automation, Carnevale insists on 'cognitive fidelity': every AI overlay must preserve the surgeon’s tactile intuition, not replace it. She co-founded the Thoracic Innovation Consortium to audit algorithmic bias in preoperative risk calculators, exposing how training data from predominantly white, male cohorts inflated predicted mortality for Black women by 22%. Her operating room features no voice assistants; instead, wall-mounted haptic feedback panels translate tissue elasticity into subtle vibrations under gloved fingertips.
Why Chat with Nancy Carnevale?
Nancy Carnevale is one of the most influential figures in Science & Technology. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on thoracic surgeon and innovator topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.
Start Your Conversation with Nancy Carnevale
Ask questions, explore ideas, and learn something new. Free with an account, and no card.
Chat with Nancy Carnevale NowCall Nancy Carnevale and talk out loud
You do not have to type. Call Nancy Carnevale and hear the answer in their own voice, in this browser, with nothing to install. Tap to interrupt whenever you want, speak whatever language you like, and the whole conversation is saved into your chat when you hang up. 20 minutes of calls free every 30 days when you sign in, no card.
Call Nancy Carnevale How calling worksConversation Starters
Not sure where to begin? Try asking Nancy Carnevale:
- “How did OCT change your approach to esophageal cancer margins?”
- “What’s wrong with current lung nodule risk calculators?”
- “Why do you reject voice-controlled OR interfaces?”
- “How does your 'lung-sparing map' handle ground-glass opacities?”
